DiscoverThe Bio ReportTeaching Tolerance to Address Autoimmune Diseases
Teaching Tolerance to Address Autoimmune Diseases

Teaching Tolerance to Address Autoimmune Diseases

Update: 2024-07-24
Share

Description

The traditional approach to treating autoimmune disease has relied on ways to suppress the immune system. COUR Pharmaceuticals is developing first-in-class therapies that instead seek to reprogram the immune system to create antigen-specific tolerance. We spoke to COUR CEO John Puisis and COUR Vice President of Research Adam Elhofy, about how the company’s immune-modifying nanoparticles work, how the approach preserves the immune response, and its partnership with Takeda focused on celiac disease.

Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Getting Tumors to Say “Eat Me”

Getting Tumors to Say “Eat Me”

2024-11-2026:54

Targeting the Dark Matter of the Genome to Treat Diseases

Targeting the Dark Matter of the Genome to Treat Diseases

2024-11-1334:19

Using AI to Discover Small Molecule Alternatives to Biologics

Using AI to Discover Small Molecule Alternatives to Biologics

2024-11-0631:33

A BET on a Novel Approach to Treat Autoimmune Conditions

A BET on a Novel Approach to Treat Autoimmune Conditions

2024-10-3024:40

Cell Therapies that Can Do a Solid for People with Cancer

Cell Therapies that Can Do a Solid for People with Cancer

2024-10-2353:31

Going to Extremes to Discover New Drugs

Going to Extremes to Discover New Drugs

2024-10-1633:29

Targeting Senescent Cells to Treat Aging-Related Diseases

Targeting Senescent Cells to Treat Aging-Related Diseases

2024-10-0933:42

Bringing Cellular Diversity into Sharper Focus

Bringing Cellular Diversity into Sharper Focus

2024-10-0232:33

Developing Cancer Therapies for When Damage Control Goes Awry

Developing Cancer Therapies for When Damage Control Goes Awry

2024-09-2519:48

Delivering the Goods

Delivering the Goods

2024-09-2537:44

Swimming in the New Oil

Swimming in the New Oil

2024-09-1124:04

Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”

Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”

2024-09-0428:49

Exploring the Promise and Peril of CRISPR

Exploring the Promise and Peril of CRISPR

2024-08-2858:25

Transforming Protein Engineering with Generative AI

Transforming Protein Engineering with Generative AI

2024-08-2136:35

Delivering Peptide Therapies Orally

Delivering Peptide Therapies Orally

2024-08-1434:54

Creating A Drug Delivery ARMMs Race

Creating A Drug Delivery ARMMs Race

2024-08-0724:42

A Seek and Destroy Approach to Disease-Causing Proteins

A Seek and Destroy Approach to Disease-Causing Proteins

2024-07-3138:55

Teaching Tolerance to Address Autoimmune Diseases

Teaching Tolerance to Address Autoimmune Diseases

2024-07-2437:24

A Bet That the Next Blockbuster May Already Be Inside You

A Bet That the Next Blockbuster May Already Be Inside You

2024-07-1723:32

A Big Mac Attack to Fight Cancer

A Big Mac Attack to Fight Cancer

2024-07-1036:37

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Teaching Tolerance to Address Autoimmune Diseases

Teaching Tolerance to Address Autoimmune Diseases

Levine Media Group